Suppr超能文献

斯里兰卡肾移植患者的两年回顾性分析。

A two-year retrospective analysis of renal transplant patients in Sri Lanka.

作者信息

Rodrigo Chaturaka, Sheriff Ricaz, Rajapakse Senaka, Lanerolle Rushika D, Sheriff Rezvi

机构信息

Department of Clinical Medicine, Faculty of Medicine, Colombo 08, Colombo, Sri Lanka.

出版信息

Saudi J Kidney Dis Transpl. 2011 Jan;22(1):174-8.

Abstract

This retrospective analytical study aimed at making a database of patients who underwent renal transplant from 31 December 2004 to 31 December 2006 under the Faculty of Medicine renal transplant program. The objective was to build a profile of renal transplant patients with focus on post KT infections and complications of renal transplants. An interviewer administered questionnaire was used. A total of 72 patients were studied; 18 (25%) had died by February 2007. Forty-three patients (58.3%) were interviewed in person, 17 were interviewed over the phone and 12 patients could not be contacted. Of those who were interviewed, 28 (38.9%) were on azathioprine, prednisolone and cyclosporine, while 15 (20.8%) were on prednisolone, cyclosporin and mycophenolate mofetil. Four patients had symptomatic cytomegalovirus infection and five had tuberculosis post transplant. Of all infections, the most commonly reported was urinary tract infection (11 cases). Thirty-three (45.8 %) had received induction therapy with either basiliximab (n = 8) or daclizumab (n = 25). Acute rejection was the most commonly encountered complication, with nine cases (12.5%) being reported over the study period. Of late complications, most were due to immunosuppression. Overall, the 2-year survival was 75%. There was no significant difference between the centers of transplant.

摘要

这项回顾性分析研究旨在建立一个2004年12月31日至2006年12月31日期间在医学院肾脏移植项目下接受肾脏移植患者的数据库。目的是建立肾脏移植患者的概况,重点关注肾移植术后感染和并发症。使用了由访员管理的问卷。总共研究了72名患者;到2007年2月,18名(25%)患者已经死亡。43名患者(58.3%)接受了面对面访谈,17名通过电话访谈,12名患者无法联系到。在接受访谈的患者中,28名(38.9%)使用硫唑嘌呤、泼尼松龙和环孢素,而15名(20.8%)使用泼尼松龙、环孢素和霉酚酸酯。4名患者有症状性巨细胞病毒感染,5名患者移植后患有结核病。在所有感染中,最常报告的是尿路感染(11例)。33名(45.8%)患者接受了巴利昔单抗(n = 8)或达利珠单抗(n = 25)的诱导治疗。急性排斥是最常见的并发症,在研究期间报告了9例(12.5%)。在晚期并发症中,大多数是由于免疫抑制。总体而言,2年生存率为75%。移植中心之间没有显著差异。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验